COMMUNIQUÉ DE PRESSE
News
-
Transparantiekennisgeving van Baltisse Groep
-
Transparency notification by Baltisse Group
-
BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
-
BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
-
Availability of the 2026 Interim Financial Report
-
Torq Announces Debt Settlement and Corporate Update
-
Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
-
Groete Access Road Nears Completion
-
MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
-
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
-
EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
-
Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
-
TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
-
Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
-
ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size